Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Diovan/Co-Diovan

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Diovan/Co-Diovan was produced by Novartis.

Novartis wins European approval for triple blood pressure pill

Faced with patent expiration for its top-selling Diovan (valsartan) blood pressure drug - which brought in $4.48bn in the first nine months of the year - Novartis has been turning to

Novartis hit by generic competition for Diovan in the UK as the drug's EU patents fall

Actavis launched generic versions of various formulations of Novartis' blood pressure drug Diovan in the UK yesterday, on the first day that patent protection expired across a number of EU member ... states. Diovan (valsartan) remains Novartis' biggest

Novartis closes three sites, cuts 2000 jobs

These include blood pressure treatment Diovan (valsartan), which is already feeling the effects of generic competition as patent protection is lost in stages over the next two years.

Novartis profits up by almost a third

Gleevic/Glivec (imatinib) and Diovan (valsartan) were the company's biggest sellers, making over $1bn each, although Diovan's sales are due to be affected by the launch of generic competition.

Valuable collection

C09 – Angiotensin II antagonists (Novartis' Diovan). •C10 – Serum lipid lowering agents (Pfizer's Lipitor).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Virtual Hackathon on Healthcare Innovation: a Customer Story
How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
OPEN Health at the World Orphan Drug Conference USA
Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
Can involving patients in design transform the clinical trial experience?
While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...

Infographics